CV5 PHARMACOECONOMIC EVALUATION OF SIMVASTATIN VERSUS “NO TREATMENT” IN PRIMARY AND SECONDARY PREVENTION OF CORONARY HEART DISEASE (CHD) IN POLAND
Abstract
Authors
A Plich KJ Filipiak J Splawinski W Gumulka
A Plich KJ Filipiak J Splawinski W Gumulka
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now